Adcy5 Protein — Adenylate Cyclase 5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Adenylate Cyclase 5 (ADCY5) is a membrane-bound enzyme that catalyzes the conversion of ATP to cyclic AMP (cAMP), a crucial second messenger involved in numerous signaling pathways in the brain. ADCY5 is particularly important in dopaminergic signaling and motor control.
Structure
ADCY5 is a large transmembrane enzyme with complex domain organization:
...
ADCY5 Protein — Adenylate Cyclase 5
Introduction
Adcy5 Protein — Adenylate Cyclase 5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Adenylate Cyclase 5 (ADCY5) is a membrane-bound enzyme that catalyzes the conversion of ATP to cyclic AMP (cAMP), a crucial second messenger involved in numerous signaling pathways in the brain. ADCY5 is particularly important in dopaminergic signaling and motor control.
Structure
ADCY5 is a large transmembrane enzyme with complex domain organization:
N-terminal Cytoplasmic Domain (C1a): First ~200 residues; forms dimer with C2 domain
First Transmembrane Region (TM1): 6 transmembrane helices
Cytoplasmic Loop (C1b): Variable region involved in regulation
Second Transmembrane Region (TM2): Additional 6 transmembrane helices
C-terminal Cytoplasmic Domain (C2a): Catalytic domain; forms active site with C1a
C2b Domain: C-terminal regulatory domain
The protein has a "M-shaped" structure with transmembrane helices forming the base and cytoplasmic catalytic domains forming the arms.
Normal Function
ADCY5 performs essential signaling functions:
cAMP Production: Catalyzes ATP → cAMP, the central second messenger in G-protein-coupled receptor (GPCR) signaling.
Dopaminergic Signaling: ADCY5 is highly expressed in striatal medium spiny [neurons](/entities/neurons) where it couples D1 dopamine receptor signaling to cAMP production<sup>[1]</sup>.
Motor Control: cAMP production in basal ganglia regulates movement initiation and motor learning.
Synaptic Plasticity: cAMP modulates synaptic strength and [long-term potentiation](/mechanisms/long-term-potentiation).
Gene Expression: cAMP activates PKA and CREB, regulating transcription of plasticity-related genes.
Role in Disease
Early-Onset Generalized Dystonia (DYT16)
Dominant ADCY5 mutations cause the most common form of genetic dystonia, characterized by rapid, involuntary muscle contractions and abnormal postures<sup>[2]</sup>. Mutations lead to:
Constitutively Active Enzyme: Some mutations cause increased basal cAMP production
Altered G-protein Coupling: Impaired regulation by Gαs proteins
Dysregulated Basal Ganglia Signaling: Abnormal cAMP levels disrupt motor circuit function
Familial Dyskinesia and Facial Myokymia
ADCY5 mutations cause a distinct syndrome with paroxysmal dyskinesias and facial myokymia.
Alzheimer's Disease
ADCY5 expression is altered in AD brains:
Reduced ADCY5 in frontal [cortex](/brain-regions/cortex) correlates with cognitive decline
Impaired cAMP signaling contributes to synaptic dysfunction
Links to [tau](/proteins/tau) pathology through PKA-mediated phosphorylation
Parkinson's Disease
Dysregulated cAMP signaling in dopaminergic neurons is implicated in PD pathogenesis, and ADCY5 may be relevant to L-DOPA-induced dyskinesias.
Therapeutic Targeting
ADCY5 and its downstream signaling are therapeutic targets:
Adenylyl Cyclase Inhibitors: Small molecules that inhibit ADCY5 activity (research use)
cAMP Modulators: PDE inhibitors that increase cAMP levels
Gene Therapy: AAV-delivered shRNA to reduce mutant allele expression (experimental)
Deep Brain Stimulation: Modulates basal ganglia circuit activity downstream of cAMP
Interactions
ADCY5 interacts with:
Gαs/Gαolf: G-protein subunits that stimulate ADCY5 activity
Gαi: Inhibitory G-protein subunit
D1 Dopamine Receptor (DRD1): Couples to ADCY5 in striatum
D2 Dopamine Receptor (DRD2): Indirectly regulates through Gi pathways
RGS Proteins: Regulators of G-protein signaling that modulate ADCY5
See Also
[ADCY5 Gene](/genes/adcy5)
[Dystonia Genes](/diseases/dystonia)
[cAMP Signaling in the Brain](/mechanisms/camp-signaling-pathway)
The study of Adcy5 Protein — Adenylate Cyclase 5 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data